Centrosome biogenesis and copy number control
Centrosome biogenesis and copy number control
批准号:
10725065
负责人:
Brendan Cormack
金额:
$4.86万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-07-01 至 2024-06-30
关键词:
AnimalsBindingBiochemistryBiogenesisBiologicalCell Cycle RegulationCell ProliferationCell divisionCell physiologyCellsCellular StructuresCentriolesCentrosomeChromosomesCiliaCompetenceContinuous Positive Airway PressureCreativenessCytoskeletonDefectDiseaseEnsureFunctional disorderG1 PhaseG2 PhaseGene ExpressionGenomeGoalsGrowthHealthHomeostasisHumanInterphaseLiquid substanceLocomotionMalignant - descriptorMalignant NeoplasmsMediatingMessenger RNAMicrocephalyMicrotubulesMitosisMitotic spindleMolecularMovementMusNoiseOpen Reading FramesOrganellesPLK1 genePhosphorylationPhosphorylation SitePlayProcentrioleProteinsRegulationResearchRoleSignal TransductionStructureTestingTranslational RegulationTranslationsVariantWorkdaughter cellgene replacementgenetic approachhuman diseaseimaging approachinsightkinetosomeprotein degradationrecruitscaffoldtumorigenesis
中文摘要
项目摘要
我们实验室的长期目标是了解控制中心粒复制和
确保细胞分裂过程中基因组的准确分布。中心粒构成了中心体的核心,
它们组织了大多数动物细胞的间期微管细胞骨架,形成了有丝分裂的极点
纺锤形。中心粒也可以被修饰以形成基本体,这是纤毛形成和发挥的模板
在细胞信号、液体运动和运动中起中心作用。来协调这些不同的细胞
加工过程中,中心粒拷贝数必须得到精确控制。细胞以两个中心粒开始G1期,
它们在S/G2期被复制,然后在
有丝分裂。我们和其他人已经证明,额外的中心粒会导致足以驱动细胞分裂的误差
恶变。了解细胞实现每周期一次复制的机制
因此,中心粒的数量是与人类健康密切相关的一个重要的基本问题。
虽然在理解中心粒的组成方面已经取得了重大进展,但仍不清楚。
中心粒形成的哪些具体步骤由酶调节蛋白Polo-like-kinase4(Plk4)控制。
同样不清楚的是,一个关键的调控步骤,即所谓的中心粒到中心体的转换(CCC),
通过使新的中心粒获得复制能力来维持中心粒的动态平衡。
我们提议的研究试图利用我们对中心粒的关键相互作用和贡献者的识别。
形成以阐明控制中心粒组装的分子机制。我们将考察三个
中心粒生物发生控制的独立成分:Plk4表达的翻译调控
Plk4对特定底物的磷酸化在中心粒组装中的影响以及一个新的功能
CCC所需的组件。目标1将定义一对保守的上游开放阅读框如何在
Plk4的mRNA调控Plk4表达的关键方面。目标2将机械地剖析一个关键的
我们在STIL上发现的Plk4磷酸化位点控制着中心粒的组装。最后,目标3将定义如何
新的中心粒蛋白PPP1R35具有促进CCC的功能。了解中心粒组装是如何进行的
调控将揭示细胞器动态平衡的基本原理,并提供对分子的洞察
人类疾病的基础是中心粒功能障碍。
英文摘要
Project Summary
The long-term goal of our lab is to understand the molecular mechanisms that control centriole duplication and
ensure the accurate distribution of the genome during cell division. Centrioles form the core of centrosomes,
which organize the interphase microtubule cytoskeleton of most animal cells and form the poles of the mitotic
spindle. Centrioles can also be modified to form basal bodies, which template the formation of cilia and play
central roles in cellular signaling, fluid movement, and locomotion. To coordinate these diverse cellular
processes, centriole copy number must be precisely controlled. Cells begin G1 phase with two centrioles,
which are duplicated during S/G2 phase and are then carefully partitioned into both daughter cells during
mitosis. We and others have shown that extra centrioles cause cell division errors that are sufficient to drive
malignant transformation. Understanding the mechanism by which cells achieve the once per cycle duplication
of the centrioles is, therefore, an important fundamental question of considerable relevance to human health.
Although significant progress has been made in understanding the composition of centrioles, it remains unclear
which specific steps in centriole formation are controlled by the enzymatic regulator Polo-like-kinase 4 (PLK4).
Equally unclear is how a critical regulatory step, termed the ‘centriole-to-centrosome conversion’ (CCC),
functions to maintain centriole homeostasis by enabling new centrioles to acquire competence for duplication.
Our proposed research seeks to capitalize on our identification of key interactions and contributors to centriole
formation to elucidate molecular mechanisms that control centriole assembly. We will examine three
independent components of centriole biogenesis control: the translational regulation of PLK4 expression, the
impact of PLK4 phosphorylation of specific substrates in centriole assembly, and the function of a new
component required for the CCC. Aim 1 will define how a pair of conserved upstream open reading frames in
the PLK4 mRNA regulate critical aspects of PLK4 expression. Aim 2 will mechanistically dissect how a critical
PLK4 phosphorylation site we identified on STIL controls centriole assembly. Finally, Aim 3 will define how a
new centriole protein, PPP1R35, functions to promote the CCC. Understanding how centriole assembly is
regulated will reveal fundamental principles of organelle homeostasis and provide insight into the molecular
basis of human diseases caused by centriole dysfunction.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.tcb.2017.01.004
发表时间:
2017-05
期刊:
Trends in cell biology
影响因子:
19
作者:
[Lambrus BG, Holland AJ]
通讯作者:
Holland AJ
DOI:
10.1083/jcb.201502088
发表时间:
2015-06-22
期刊:
The Journal of cell biology
影响因子:
--
作者:
[Moyer TC, Clutario KM, Lambrus BG, Daggubati V, Holland AJ]
通讯作者:
Holland AJ
DOI:
10.1016/j.tranon.2018.04.001
发表时间:
2018-06
期刊:
Translational oncology
影响因子:
5
作者:
[Heerma van Voss MR, Kammers K, Vesuna F, Brilliant J, Bergman Y, Tantravedi S, Wu X, Cole RN, Holland A, van Diest PJ, Raman V]
通讯作者:
Raman V
DOI:
10.1083/jcb.201502089
发表时间:
2015-07-06
期刊:
The Journal of cell biology
影响因子:
--
作者:
[Lambrus BG, Uetake Y, Clutario KM, Daggubati V, Snyder M, Sluder G, Holland AJ]
通讯作者:
Holland AJ
DOI:
10.1016/bs.mcb.2015.03.017
发表时间:
2015
期刊:
Methods in cell biology
影响因子:
--
作者:
[Moyer TC, Holland AJ]
通讯作者:
Holland AJ
共 17 条
Cryptococcus neoformans factors contributing to penetration of the blood-brain barrier
-
批准号:10170285
-
项目类别:
-
资助金额:$20.47万
-
财政年份:2020
-
负责人:Brendan Cormack
-
依托单位:
Cryptococcus neoformans factors contributing to penetration of the blood-brain barrier
-
批准号:10079284
-
项目类别:
-
资助金额:$24.56万
-
财政年份:2020
-
负责人:Brendan Cormack
-
依托单位:
Molecular mechanism that suppresses the proliferation of cells with supernumerary centrioles
-
批准号:10458557
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2019
-
负责人:Brendan Cormack
-
依托单位:
Centrosome biogenesis and copy number control
-
批准号:10382332
-
项目类别:
-
资助金额:$34.01万
-
财政年份:2015
-
负责人:Brendan Cormack
-
依托单位:
Centrosome biogenesis and copy number control
-
批准号:10559924
-
项目类别:
-
资助金额:$7.29万
-
财政年份:2015
-
负责人:Brendan Cormack
-
依托单位:
Centrosome biogenesis and copy number control
-
批准号:10582649
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2015
-
负责人:Brendan Cormack
-
依托单位:
AIDS Opportunistic Pathogens: Targeting the Methyl Citrate Cycle
-
批准号:7620189
-
项目类别:
-
资助金额:$22.74万
-
财政年份:2009
-
负责人:Brendan Cormack
-
依托单位:
AIDS Opportunistic Pathogens: Targeting the Methyl Citrate Cycle
-
批准号:7911623
-
项目类别:
-
资助金额:$20.5万
-
财政年份:2009
-
负责人:Brendan Cormack
-
依托单位:
Pathogenesis of Candida glabrata in the Urinary Tract
-
批准号:7868931
-
项目类别:
-
资助金额:$2.8万
-
财政年份:2009
-
负责人:Brendan Cormack
-
依托单位:
Pathogenesis of Candida glabrata in the Urinary Tract
-
批准号:8062115
-
项目类别:
-
资助金额:$31.27万
-
财政年份:2007
-
负责人:Brendan Cormack
-
依托单位:
Pathogenesis of Candida glabrata in the Urinary Tract
-
批准号:7266496
-
项目类别:
-
资助金额:$33.84万
-
财政年份:2007
-
负责人:Brendan Cormack
-
依托单位:
Pathogenesis of Candida glabrata in the Urinary Tract
-
批准号:7615689
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2007
-
负责人:Brendan Cormack
-
依托单位:
AIDS Opportunistic Pathogens/Fungal Cell Wall Drug Targets
-
批准号:7005859
-
项目类别:
-
资助金额:$20.38万
-
财政年份:2005
-
负责人:Brendan Cormack
-
依托单位:
AIDS Opportunistic Pathogens/Fungal Cell Wall Drug Targets
-
批准号:7104353
-
项目类别:
-
资助金额:$19.96万
-
财政年份:2005
-
负责人:Brendan Cormack
-
依托单位:
PATHOGENESIS OF CANDIDA GLABRATA IN THE URINARY TRACT
-
批准号:6501062
-
项目类别:
-
资助金额:$12.98万
-
财政年份:2001
-
负责人:Brendan Cormack
-
依托单位:
AIDS Opportunistic Infectious: Virulence of C. glabrata
-
批准号:6867397
-
项目类别:
-
资助金额:$40.88万
-
财政年份:1999
-
负责人:Brendan Cormack
-
依托单位:
AIDS Opportunistic Infections: Virulence of C. glabrata
-
批准号:7999229
-
项目类别:
-
资助金额:$40.59万
-
财政年份:1999
-
负责人:Brendan Cormack
-
依托单位:
AIDS OPPORTUNISTIC INFECTIONS--VIRULENCE OF C GLABRATA
-
批准号:6510915
-
项目类别:
-
资助金额:$31.49万
-
财政年份:1999
-
负责人:Brendan Cormack
-
依托单位:
AIDS OPPORTUNISTIC INFECTIONS--VIRULENCE OF C GLABRATA
-
批准号:6632046
-
项目类别:
-
资助金额:$32.44万
-
财政年份:1999
-
负责人:Brendan Cormack
-
依托单位:
AIDS OPPORTUNISTIC INFECTIONS--VIRULENCE OF C GLABRATA
-
批准号:6374292
-
项目类别:
-
资助金额:$30.57万
-
财政年份:1999
-
负责人:Brendan Cormack
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: